← Back to all signals
RESEARCH PAPER ANALYSIS

Embryoid Bodies and Related Proliferations in Ovarian Germ Cell Tumors.

AI interpretation is pending for this paper.

Open original publication →
PMID38963187
JournalThe American journal of surgical pathology
Publication Date2024-07-04
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

We investigated the frequency and associated pathology of embryoid bodies in ovarian tumors by evaluating neoplasms in which they are known to occur: 100 immature teratomas, 125 malignant mixed germ cell tumors, and 6 polyembryomas. Three immature teratomas contained a single relatively well-formed embryoid body, whereas these and 11 others showed foci we categorized as embryoid body remnants consisting of microscopic aggregates of embryonal or yolk sac-type epithelium associated with spaces consistent with yolk sac or amniotic cavity but lacking a classic embryoid body structure. Teratomas with these foci were all high grade. A well-formed embryoid body was found in only 1 malignant mixed tumor, but embryoid body remnants were present in 25%, invariably associated with foci of immature teratoma (100%) and often with yolk sac tumor (97%), embryonal carcinoma (35%), or both (32%). These foci usually took the form of round to oval aggregates, often well-circumscribed, for which the term "polyembryoma background" has been proposed. The polyembryomas were typically grossly hemorrhagic and occurred in patients from 9 to 43 years of age. The embryoid bodies in them generally grew in lobules within an edematous to occasionally myxoid stroma. Four tumors contained liver-like cells, 4 numerous glands likely recapitulating the allantois, 3 syncytiotrophoblast cells, 2 prominent cysts, and 2 striking vascular proliferations. This study indicates that (1) typical embryoid bodies are rare in immature teratomas but about 14% of them have embryoid body remnants. (2) Embryoid body remnants are seen in 25% of malignant mixed germ cell tumors with a teratomatous component and often proliferate to form yolk sac tumor and embryonal carcinoma. (3) Well-formed embryoid bodies growing in a confluent manner (polyembryoma) are rare, and minor foci of teratoma, yolk sac tumor, or embryonal carcinoma are almost always present, indicating that these are fundamentally malignant mixed germ cell tumors but the polyembryoma component is dominant and distinctive which, in our opinion, justifies its own nomenclature. (4) Embryoid bodies are not a feature of other germ cell tumors.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Men's Self-Reported Knowledge and Awareness Towards Male Breast Cancer in Saudi Arabia: A Cross-Sectional Study. Cancer control : journal of the Moffitt Cancer Center 65.2 2 Deep learning-based automated segmentation of target volumes for pediatric craniospinal irradiation in proton therapy. Radiation oncology (London, England) 60.74 3 Fertility-related distress and female identity reconstruction among reproductive-age women with breast cancer in China: a qualitative study. BMC women's health 61.9 4 Awake craniotomy for drug-resistant non-oncological epilepsy: a systematic review of feasibility, reported safety, and seizure outcomes. BMC surgery 77.06 5 Exosomal microRNAs in tumor-heart crosstalk: nanobiological mechanisms and therapeutic implications. Journal of nanobiotechnology 71.09 6 Quantifying the social net: a nomogram to predict baseline quality of life at clinical entry for head and neck cancer. World journal of surgical oncology 65.7 7 A comprehensive assessment of cervical cancer risk factors, screening modalities, and cytological outcomes. JPMA. The Journal of the Pakistan Medical Association 57.5 8 Location Matters: Expanding Advanced Practice Provider Roles to Increase Access to Specialized Adolescent and Young Adult Oncology Care. Journal of the advanced practitioner in oncology 64.0 9 Risk factors and predictive value of lung ultrasound aeration score for postoperative pulmonary complications in pediatric patients undergoing abdominal tumor resection: a prospective observational study. BMC anesthesiology 57.5 10 Clinical outcomes of T-cell acute lymphoblastic leukemia versus T-cell lymphoblastic lymphoma after allogeneic hematopoietic stem cell transplantation. Annals of hematology 65.5 11 [A Multicenter Retrospective Investigation of the Distribution of High-Risk HPV Genotypes Among Women Who Underwent HPV Testing in Azerbaijan]. Mikrobiyoloji bulteni 57.5 12 Frequency of Thiopurine S-methyltransferase (TPMT) Genotypes Among Patients With Acute Lymphoblastic Leukemia at a Tertiary Care Hospital in Bangladesh: A Cross-Sectional Study. Cureus 66.2 13 Temporary arterial clamping in major musculoskeletal malignant tumour surgery: A two-centre comparative study. Cardiovascular journal of Africa 59.5 14 Hilar cysts in jaundiced neonates: Diagnostic challenges and surgical outcomes at a National Pediatric Referral Center in Colombia. Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica 58.9 15 Endoscopic cryoprobes in the pediatric airway: Initial experience. Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica 65.6 16 [Analysis of influencing factors for the occurrence of transient hypernatremia in patients with extremely severe burns]. Zhonghua shao shang yu chuang mian xiu fu za zhi 76.8 17 Fear of cancer recurrence in caregivers of paediatric cancer survivors in Singapore. Annals of the Academy of Medicine, Singapore 47.5 18 The feasibility of training nnU-Net to segment pediatric Wilms tumor with small datasets. Frontiers in oncology 66.0 19 Risk factors for persistent high-risk HPV infection and recurrence burden of vaginal infections in women with cervical low-grade squamous intraepithelial lesions: a retrospective cohort study. Frontiers in cellular and infection microbiology 70.0 20 DeepOSSA: a deep learning framework for personalized survival prediction in osteosarcoma patients. Frontiers in cell and developmental biology 62.72 21 Case Report: Diagnostic and management challenges of necrotizing fasciitis in an immunocompromised child with acute lymphoblastic leukaemia. Frontiers in surgery 54.6 22 Juvenile xanthogranuloma mimicking malignancy at uncommon sites in children: five cases and a systematic review. Frontiers in oncology 71.5 23 Human Gut Microbiota of Healthy Individuals Show Resilience to Acute Aflatoxin B1 Exposure Despite Solvent-Driven Community Shifts. bioRxiv : the preprint server for biology 43.9 24 First-in-human quad-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial. Research square 79.4 25 Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs. bioRxiv : the preprint server for biology 54.1 26 PedDx: An End-to-End Deep Learning Framework for Pediatric Posterior Fossa Tumor Diagnosis with Agentic AI-Enabled Independent External Evaluation. medRxiv : the preprint server for health sciences 61.0 27 Reproductive Choices and Family-building Decision Uncertainty Among Young Women at Familial Risk for Breast Cancer. Research square 66.0 28 Solitary Neurofibroma in the Submental Region of a 15-Year-Old Adolescent: A Case Report and Review of Literature. International medical case reports journal 49.9 29 Lifetime Hormonal Exposure and Risk of Lung Cancer in Women: Results From a French Population-Based Case-Control Study (The WELCA Study). Cancer medicine 69.0 30 Histotripsy for Hepatocellular Carcinoma in Asia-Pacific: Current Evidence, Evidence Gaps, and Future Research Priorities. Journal of hepatocellular carcinoma 71.6 31 ISR addiction: Co-opting a stress sentinel to fuel tumor resilience and therapy resistance. Neoplasia (New York, N.Y.) 68.84 32 Late Presentation of Fetus in Fetu in a 10-Year-Old Boy. Case reports in pediatrics 38.5
PATIENT-FRIENDLY SUMMARY

Embryoid Bodies and Related Proliferations in Ovarian Germ Cell Tumors.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic